| Product NDC: | 0228-2996 |
| Proprietary Name: | Tamsulosin hydrochloride |
| Non Proprietary Name: | Tamsulosin hydrochloride |
| Active Ingredient(s): | .4 mg/1 & nbsp; Tamsulosin hydrochloride |
| Administration Route(s): | ORAL |
| Dosage Form(s): | CAPSULE |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 0228-2996 |
| Labeler Name: | Actavis Elizabeth LLC |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA078801 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20100427 |
| Package NDC: | 0228-2996-11 |
| Package Description: | 100 CAPSULE in 1 BOTTLE (0228-2996-11) |
| NDC Code | 0228-2996-11 |
| Proprietary Name | Tamsulosin hydrochloride |
| Package Description | 100 CAPSULE in 1 BOTTLE (0228-2996-11) |
| Product NDC | 0228-2996 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Tamsulosin hydrochloride |
| Dosage Form Name | CAPSULE |
| Route Name | ORAL |
| Start Marketing Date | 20100427 |
| Marketing Category Name | ANDA |
| Labeler Name | Actavis Elizabeth LLC |
| Substance Name | TAMSULOSIN HYDROCHLORIDE |
| Strength Number | .4 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Adrenergic alpha-Antagonists [MoA],alpha-Adrenergic Blocker [EPC] |